GlassScriptPhysician profile
James S Wysock
NPI 1538328810
$62,030.46
in general payments reported to CMS, 2019-2025
22 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,378 · 2020: $3,201 · 2021: $205 · 2022: $360 · 2023: $12K · 2024: $18K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $12K · Food and Beverage: $6,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,713.87 |
| Travel and Lodging | $12,257.40 |
| Food and Beverage | $6,915.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $51,942.43 | 2023-2025 | |
| Intuitive Surgical, INC. | $7,129.62 | 2019-2025 | |
| Angiodynamics, INC. | $487.36 | 2021-2023 | Nanoknife |
| Boston Scientific Corporation | $408.98 | 2019-2024 | Spaceoar Vue System - 10ml |
| Agiliti Surgical, INC. | $344.71 | 2023-2024 | Endocare Cryocare Cs System, Koelis Trinity Fusion Biopsy System, Cryocare Cs |
| Abbvie INC. | $257.60 | 2023 | Botox |
| Urogen Pharma, INC. | $211.19 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $161.09 | 2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $149.70 | 2024 | |
| Ambu INC. | $138.96 | 2025 | |
| Janssen Scientific Affairs, LLC | $129.91 | 2025 | Erleada, Balversa, Pipeline |
| Healthtronics Stone Solutions, LLC | $125.00 | 2019 | |
| Profound Medical Corp. | $104.40 | 2022 | |
| Biotissue Holdings INC. | $95.00 | 2019 | |
| Galvanize Therapeutics, INC | $74.46 | 2025 | Aliya System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $67.68 | 2022 | |
| Koelis INC. | $61.02 | 2024 | |
| Civco Medical Instruments | $38.96 | 2025 | |
| Dendreon Pharmaceuticals LLC | $30.41 | 2025 | Provenge |
| Dentsply Ih Ab | $24.89 | 2023 | Lofric |
| Astellas Pharma US INC | $24.26 | 2023 | Myrbetriq |
| Medtronic, INC. | $22.83 | 2023 | Endo Clip III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wysock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.